UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab for the first-line treatment of non-small cell lung cancer

Expert opinion on biological therapy, 2018-10, Vol.18 (10), p.1015-1021

2018

Volltextzugriff (PDF)

SY20-3 Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

Annals of oncology, 2022-07, Vol.33, p.S444

Ninomiya, Kiichiro

2022

Volltextzugriff (PDF)

Pilot evaluation of a HER2 testing in non-small-cell lung cancer

Journal of clinical pathology, 2020-06, Vol.73 (6), p.353-357

2020

Volltextzugriff (PDF)

Radiation-Induced Lung Injury With Lung Cancer Treated With the Combination Therapy of Nintedanib and Dexamethasone

Curēus (Palo Alto, CA), 2023-09

2023

Volltextzugriff (PDF)

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

International journal of clinical oncology, 2019-01, Vol.24 (1), p.41-45

2019

Volltextzugriff (PDF)

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

International journal of clinical oncology, 2019-05, Vol.24 (5), p.461-467

2019

Volltextzugriff (PDF)

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Acta oncologica, 2020-03, Vol.59 (3), p.249-256

2020

Volltextzugriff (PDF)

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Supportive care in cancer, 2021-09, Vol.29 (9), p.5237-5244

2021

Volltextzugriff (PDF)

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Internal Medicine, 2024, pp.2938-23

2024

Volltextzugriff (PDF)

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

Internal Medicine, 2021/09/01, Vol.60(17), pp.2831-2837

2021

Volltextzugriff (PDF)

Identification of targetable kinases in idiopathic pulmonary fibrosis

Respiratory research, 2022-02, Vol.23 (1), p.20-20, Article 20

2022

Volltextzugriff (PDF)

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.86-93

2019

Volltextzugriff (PDF)

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.83-89

2020

Volltextzugriff (PDF)

肺癌診療ガイドライン改訂のポイント―薬物療法の領域を中心に

肺癌, 2023/11/02, Vol.63(Supplement), pp.804-805

2023

Volltextzugriff (PDF)

Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients

Respiratory investigation, 2021-03, Vol.59 (2), p.240-246

2021

Volltextzugriff (PDF)

Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol

Acta medica Okayama, 2018-06, Vol.72 (3), p.319-323

2018

Volltextzugriff (PDF)

Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Acta oncologica, 2020-03, Vol.59 (3), p.324-328

2020

Volltextzugriff (PDF)

Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report

Thoracic cancer, 2024-06, Vol.15 (17), p.1390-1394

2024

Volltextzugriff (PDF)

Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy

Respiratory medicine case reports, 2024-01, Vol.51, p.102104, Article 102104

2024

Volltextzugriff (PDF)

Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report

Case reports in oncology, 2022-05, Vol.15 (2), p.494-498

2022

Volltextzugriff (PDF)

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction

Oncology letters, 2020-12, Vol.20 (6), p.1-1

2020

Volltextzugriff (PDF)

Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization

Respiratory medicine case reports, 2022-01, Vol.38, p.101669, Article 101669

2022

Volltextzugriff (PDF)

Key Points of the Revision of Japanese Lung Cancer Treatment Guideline in 2023

Haigan, 2023/11/02, Vol.63(Supplement), pp.804-805

2023

Volltextzugriff (PDF)

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations

JTO clinical and research reports, 2021-01, Vol.2 (1), p.100107, Article 100107

2021

Volltextzugriff (PDF)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

JTO clinical and research reports, 2023-12, Vol.4 (12), p.100593-100593, Article 100593

2023

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(82)
Berichte
(4)

Sprache

Englisch
(72)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab for the first-line treatment of non-small cell lung cancer

SY20-3 Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

Pilot evaluation of a HER2 testing in non-small-cell lung cancer

Radiation-Induced Lung Injury With Lung Cancer Treated With the Combination Therapy of Nintedanib and Dexamethasone

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

Identification of targetable kinases in idiopathic pulmonary fibrosis

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

肺癌診療ガイドライン改訂のポイント―薬物療法の領域を中心に

Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients

Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol

Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report

Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy

Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction

Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization

Key Points of the Revision of Japanese Lung Cancer Treatment Guideline in 2023

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

Aktive Filter

Suchergebnisse filtern